Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment
- PMID: 3350290
- DOI: 10.1016/0016-5085(88)90013-3
Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment
Abstract
The amount of bile acid excreted via an ileostomy at the end of the ileum should give an estimate of the amount of bile acid transported to the colon. In the present study, 8 patients with ileostomies at the end of the ileum but without disease or resection of the small intestine excreted 1690 +/- 205 mumol/day (mean +/- SEM) of bile acids from the ileostomies. In comparison with duodenal bile, cholic acid was increased at the end of the ileum and chenodeoxycholic acid decreased; in addition, bile acid sulfates were increased and bile acid glucuronides were decreased. When ursodeoxycholic acid, a bile acid that decreases biliary cholesterol saturation and dissolves gallstones, was administered at a dose of 500 mg to each subject, 59% +/- 8% (mean +/- SEM) of this bile acid was excreted within 24 h from the ileostomies. It is apparent from these studies that absorption of ursodeoxycholic acid from the small intestine is slower than previously anticipated and involves the entire small intestine and probably also the colon.
Similar articles
-
Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.Gastroenterology. 1990 Feb;98(2):424-8. doi: 10.1016/0016-5085(90)90834-n. Gastroenterology. 1990. PMID: 2295398
-
Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.Dig Dis Sci. 1982 Feb;27(2):161-8. doi: 10.1007/BF01311711. Dig Dis Sci. 1982. PMID: 7075411
-
Effect of litholytic bile acids on cholesterol absorption in gallstone patients.Gastroenterology. 1983 Feb;84(2):265-71. Gastroenterology. 1983. PMID: 6848406 Clinical Trial.
-
Intestinal absorption of bile acids: effect of ursodeoxycholic acid treatment.Ital J Gastroenterol. 1995 May;27(4):193-5. Ital J Gastroenterol. 1995. PMID: 8520037 Review.
-
Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.Dig Dis Sci. 1989 Dec;34(12 Suppl):5S-15S. doi: 10.1007/BF01536656. Dig Dis Sci. 1989. PMID: 2689116 Review.
Cited by
-
Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.Dig Dis Sci. 2006 Mar;51(3):618-22. doi: 10.1007/s10620-006-3180-5. Dig Dis Sci. 2006. PMID: 16614977
-
Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.Gut. 2003 Sep;52(9):1371-5. doi: 10.1136/gut.52.9.1371. Gut. 2003. PMID: 12912872 Free PMC article.
-
Rapid cholesterol nucleation time and cholesterol gall stone formation after subtotal or total colectomy in humans.Gut. 1994 Dec;35(12):1760-4. doi: 10.1136/gut.35.12.1760. Gut. 1994. PMID: 7829016 Free PMC article.
-
Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.Eur J Clin Pharmacol. 1993;45(3):221-5. doi: 10.1007/BF00315387. Eur J Clin Pharmacol. 1993. PMID: 8276045 Clinical Trial.
-
Ursodeoxycholic acid in the treatment of liver diseases.Postgrad Med J. 1997 Feb;73(856):75-80. doi: 10.1136/pgmj.73.856.75. Postgrad Med J. 1997. PMID: 9122101 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources